当前位置:
X-MOL 学术
›
Nat. Rev. Gastroenterol. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Perioperative cetuximab plus chemotherapy reduces overall survival in metastatic disease.
Nature Reviews Gastroenterology & Hepatology ( IF 45.9 ) Pub Date : 2020-02-21 , DOI: 10.1038/s41575-020-0277-9 Iain Dickson 1
中文翻译:
围手术期西妥昔单抗加化疗会降低转移性疾病的总体生存率。
更新日期:2020-02-21
Nature Reviews Gastroenterology & Hepatology ( IF 45.9 ) Pub Date : 2020-02-21 , DOI: 10.1038/s41575-020-0277-9 Iain Dickson 1
Affiliation
中文翻译:
围手术期西妥昔单抗加化疗会降低转移性疾病的总体生存率。